R. Verdon et al., EVALUATION OF HIGH-DOSE REGIMEN OF PAROMOMYCIN AGAINST CRYPTOSPORIDIOSIS IN THE DEXAMETHASONE-TREATED RAT MODEL, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 2155-2157
In the dexamethasone-treated rat model of cryptosporidiosis, paromomyc
in was effective at a dosage of 50 mg/kg/day or more for ileal infecti
on and 200 mg/kg/day or more for cecal infection. At 1 and 3 weeks aft
er treatment, a persistent infection was demonstrated in all rats. The
se results confirm the anticryptosporidial activity of paromomycin and
underscore the limitations of this compound because of its potential
toxicity at such high dosages and its inability to eradicate the infec
tion.